Showing results (501-510 of 652) with videos related to

Sort By:
Pageof 66
Critical Care Medicine|December 20, 2007
Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter dataElie Azoulay, Djamel Mokart, Antoine Rabbat, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2010
Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trialElie Azoulay, Djamel Mokart, Jérôme Lambert, et al.
Hepatology (Baltimore, Md.)|December 7, 2011
Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicitiesJean-Claude Trinchet, Cendrine Chaffaut, Valérie Bourcier, et al.
Blood|December 3, 2015
Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletionVirginie Chesnais, Aline Renneville, Andrea Toma, et al.
Transfusion|September 21, 2007
Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresisFrançois Lefrère, Sarah Zohar, Sandrine Beaudier, et al.
AIDS (London, England)|May 30, 2024
Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirineEmma Rubenstein, Myriam Diemer, Lauriane Goldwirt, et al.
Blood|September 28, 2010
Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasmsFanny Baran-Marszak, Hajer Magdoud, Christophe Desterke, et al.
Leukemia & Lymphoma|April 12, 2017
A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasoneVéronique Leblond, Pierre Morel, Marie-Sarah Dilhuidy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and olderClaude Gardin, Sylvie Chevret, Cécile Pautas, et al.
Cancer|April 8, 2015
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL groupThorsten Braun, Sophie Cereja, Sylvie Chevret, et al.
Pageof 66